JP2002512800A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002512800A5 JP2002512800A5 JP2000546017A JP2000546017A JP2002512800A5 JP 2002512800 A5 JP2002512800 A5 JP 2002512800A5 JP 2000546017 A JP2000546017 A JP 2000546017A JP 2000546017 A JP2000546017 A JP 2000546017A JP 2002512800 A5 JP2002512800 A5 JP 2002512800A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- polynucleotide
- nucleotide sequence
- isolated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9808866.9A GB9808866D0 (en) | 1998-04-24 | 1998-04-24 | Novel compounds |
| GB9808866.9 | 1998-04-24 | ||
| PCT/EP1999/002766 WO1999055873A2 (en) | 1998-04-24 | 1999-04-20 | Basb006 polynucleotide(s) and polypeptides from neisseria meningitis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010044312A Division JP2010166920A (ja) | 1998-04-24 | 2010-03-01 | 髄膜炎菌由来のｂａｓｂ００６ポリヌクレオチドおよびポリペプチド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002512800A JP2002512800A (ja) | 2002-05-08 |
| JP2002512800A5 true JP2002512800A5 (enExample) | 2006-04-27 |
| JP4718009B2 JP4718009B2 (ja) | 2011-07-06 |
Family
ID=10830985
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000546017A Expired - Fee Related JP4718009B2 (ja) | 1998-04-24 | 1999-04-20 | 髄膜炎菌由来のｂａｓｂ００６ポリヌクレオチドおよびポリペプチド |
| JP2010044312A Pending JP2010166920A (ja) | 1998-04-24 | 2010-03-01 | 髄膜炎菌由来のｂａｓｂ００６ポリヌクレオチドおよびポリペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010044312A Pending JP2010166920A (ja) | 1998-04-24 | 2010-03-01 | 髄膜炎菌由来のｂａｓｂ００６ポリヌクレオチドおよびポリペプチド |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US6696062B1 (enExample) |
| EP (2) | EP1071783A2 (enExample) |
| JP (2) | JP4718009B2 (enExample) |
| CN (1) | CN1203180C (enExample) |
| AU (1) | AU3928499A (enExample) |
| CA (1) | CA2326375A1 (enExample) |
| GB (1) | GB9808866D0 (enExample) |
| WO (1) | WO1999055873A2 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9813930A (pt) * | 1997-11-06 | 2006-12-19 | Chiron Spa | antìgeno neisserial |
| US6914131B1 (en) | 1998-10-09 | 2005-07-05 | Chiron S.R.L. | Neisserial antigens |
| GB9808866D0 (en) * | 1998-04-24 | 1998-06-24 | Smithkline Beecham Biolog | Novel compounds |
| GB9911683D0 (en) * | 1999-05-19 | 1999-07-21 | Chiron Spa | Antigenic peptides |
| EP1179072A2 (en) | 1999-05-19 | 2002-02-13 | Chiron S.P.A. | Combination neisserial compositions |
| PT2275551E (pt) | 1999-10-29 | 2015-06-29 | Novartis Vaccines & Diagnostic | Péptidos antigénicos de neisseria |
| GB9928196D0 (en) | 1999-11-29 | 2000-01-26 | Chiron Spa | Combinations of B, C and other antigens |
| ES2588917T3 (es) | 2000-01-17 | 2016-11-07 | Glaxosmithkline Biologicals Sa | Vacuna de VME suplementada contra meningococo |
| PT2270030E (pt) | 2000-02-28 | 2012-07-24 | Novartis Vaccines & Diagnostic | Expressão heteróloga de proteínas de neisseria |
| GB0103171D0 (en) | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
| ES2615362T3 (es) * | 2001-07-27 | 2017-06-06 | Glaxosmithkline Biologicals Sa | Adhesinas de meningococos |
| RU2364418C2 (ru) * | 2002-08-02 | 2009-08-20 | ГлаксоСмитКлайн Байолоджикалз с.а. | ВАКЦИННЫЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ЛИПОПОЛИСАХАРИДЫ ИММУНОТИПА L2 И/ИЛИ L3, ПРОИСХОДЯЩИЕ ИЗ ШТАММА NEISSERIA MENINGITIDIS IgtB- |
| CN1674933B (zh) | 2002-08-02 | 2012-09-26 | 葛兰素史密丝克莱恩生物有限公司 | 疫苗组合物 |
| EP2351579B1 (en) | 2002-10-11 | 2016-09-21 | Novartis Vaccines and Diagnostics S.r.l. | Polypeptide vaccines for broad protection against hypervirulent meningococcal lineages |
| AU2004277342B2 (en) | 2003-10-02 | 2010-12-16 | Glaxosmithkline Biologicals S.A. | Pertussis antigens and use thereof in vaccination |
| US20080280987A1 (en) * | 2006-08-31 | 2008-11-13 | Desai Neil P | Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases |
| MX2010012999A (es) | 2008-05-30 | 2012-03-07 | U S A As Represented By The Secretary Of The Army On Behalf Of Walter Reed Army | Vacuna de vesícula de membrana externa nativa multivalente del meningococo, método para su fabricación y uso. |
| EP2544714A1 (en) | 2010-03-10 | 2013-01-16 | GlaxoSmithKline Biologicals S.A. | Vaccine composition |
| CA2792691A1 (en) | 2010-03-11 | 2011-09-15 | Glaxosmithkline Biologicals S.A. | Immunogenic composition or vaccine against gram-negative bacterial, for example, neisserial, infection or disease |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| JPH01125328A (ja) | 1987-07-30 | 1989-05-17 | Centro Natl De Biopreparados | 髄膜炎菌ワクチン |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| GB9022190D0 (en) | 1990-10-12 | 1990-11-28 | Perham Richard N | Immunogenic material |
| FR2682041B1 (fr) | 1991-10-03 | 1994-01-14 | Pasteur Merieux Serums Vaccins | Vaccin contre les infections a neisseria meningitidis. |
| DE69313134T2 (de) | 1992-06-25 | 1998-02-26 | Smithkline Beecham Biolog | Adjuvantien enthaltende impfstoffzusammensetzung |
| KR100310510B1 (ko) | 1993-03-23 | 2002-07-04 | 장 스테판느 | 3-0-탈아세틸화모노포스포릴지질a를함유하는백신조성물 |
| AU695869B2 (en) | 1993-04-06 | 1998-08-27 | Fred Hutchinson Cancer Research Center | Chimeric cytokine receptors in lymphocytes |
| JPH08508889A (ja) | 1993-06-07 | 1996-09-24 | アムジエン・インコーポレーテツド | ハイブリッドレセプター分子 |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| AU713040B2 (en) | 1994-07-15 | 1999-11-18 | University Of Iowa Research Foundation, The | Immunomodulatory oligonucleotides |
| US6245337B1 (en) * | 1994-08-25 | 2001-06-12 | Washington University | Haemophilus adherence and penetration proteins |
| US6121037A (en) * | 1994-10-18 | 2000-09-19 | Stojiljkovic; Igor | Bacterial hemoglobin receptor genes |
| US6265567B1 (en) * | 1995-04-07 | 2001-07-24 | University Of North Carolina At Chapel Hill | Isolated FrpB nucleic acid molecule |
| EP0821737A4 (en) | 1995-04-21 | 2005-01-19 | Human Genome Sciences Inc | NUCLEOTIDE SEQUENCE OF THE GENOME HAEMOPHILUS INFLUENZAE RD, THE FRAGMENTS THEREOF, AND ITS APPLICATIONS |
| UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| CU22559A1 (es) * | 1996-01-17 | 1999-05-03 | Ct Ingenieria Genetica Biotech | Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión |
| DE69708318T3 (de) * | 1996-08-27 | 2006-11-16 | Novartis Vaccines and Diagnostics, Inc., Emeryville | Neisseria meningitidis serogruppe b glykokonjugate und verfahren zu deren verwendung |
| US6914131B1 (en) | 1998-10-09 | 2005-07-05 | Chiron S.R.L. | Neisserial antigens |
| BR9813930A (pt) * | 1997-11-06 | 2006-12-19 | Chiron Spa | antìgeno neisserial |
| GB9808734D0 (en) * | 1998-04-23 | 1998-06-24 | Smithkline Beecham Biolog | Novel compounds |
| GB9808866D0 (en) * | 1998-04-24 | 1998-06-24 | Smithkline Beecham Biolog | Novel compounds |
| US7666988B1 (en) * | 1999-03-12 | 2010-02-23 | Glaxosmithkline Biologicals S.A. | BASB082 Polypeptides |
| GB0025171D0 (en) * | 2000-10-13 | 2000-11-29 | Smithkline Beecham Biolog | Novel compounds |
| ES2615362T3 (es) * | 2001-07-27 | 2017-06-06 | Glaxosmithkline Biologicals Sa | Adhesinas de meningococos |
-
1998
- 1998-04-24 GB GBGB9808866.9A patent/GB9808866D0/en not_active Ceased
-
1999
- 1999-04-20 EP EP99922122A patent/EP1071783A2/en not_active Withdrawn
- 1999-04-20 CN CNB998077712A patent/CN1203180C/zh not_active Expired - Fee Related
- 1999-04-20 JP JP2000546017A patent/JP4718009B2/ja not_active Expired - Fee Related
- 1999-04-20 EP EP10011715A patent/EP2360260A1/en not_active Withdrawn
- 1999-04-20 AU AU39284/99A patent/AU3928499A/en not_active Abandoned
- 1999-04-20 CA CA002326375A patent/CA2326375A1/en not_active Abandoned
- 1999-04-20 US US09/673,896 patent/US6696062B1/en not_active Expired - Fee Related
- 1999-04-20 WO PCT/EP1999/002766 patent/WO1999055873A2/en not_active Ceased
-
2003
- 2003-12-19 US US10/742,345 patent/US7419824B2/en not_active Expired - Fee Related
-
2008
- 2008-07-25 US US12/180,055 patent/US20100196409A1/en not_active Abandoned
-
2010
- 2010-03-01 JP JP2010044312A patent/JP2010166920A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2693145B2 (ja) | 乳頭腫ウイルス型特異的抗体 | |
| Svehag et al. | THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY: II. 19S and 7S Antibody Formation: Differences in Antigen Dose Requirement for Sustained Synthesis, Anamnesis, and Sensitivity to X-Irradiation | |
| JP2010166921A5 (enExample) | ||
| KR860700090A (ko) | 어드헤신(Adhesin)항원 | |
| RU99122686A (ru) | Модифицированные молекулы фно альфа, днк, кодирующие эти модифицированные молекулы фно альфа, и вакцины, включающие эти модифицированные молекулы фно альфа и днк | |
| CN86102858A (zh) | 制备猪支原体的重组表面抗原及其疫苗的方法 | |
| JP2006523453A5 (enExample) | ||
| US20090074781A1 (en) | Dengue virus peptide vaccine and methods of preparing and using the same | |
| CA2217522A1 (en) | Isolated frpb nucleic acid molecule and vaccine | |
| WO2022071513A1 (ja) | ＳＡＲＳ－ＣｏＶ－２に対する改良型ＤＮＡワクチン | |
| CN1045603A (zh) | 筛选系统 | |
| CN113186223A (zh) | 一种新冠病毒疫苗的表达载体及其构建方法、应用和疫苗 | |
| JPS63115825A (ja) | 中和糖タンパク質のペプチド | |
| JP4820489B2 (ja) | ヒト型結核菌により発現され且つｂｃｇによって発現されないタンパク質、ならびに診断薬およびワクチンとしてのそれらの使用 | |
| CN116970058B (zh) | 针对tp53基因r249s突变的肿瘤新抗原多肽及其应用 | |
| CA2719041C (en) | A method for identifying polypeptides which comprise a cross-reactive antigenic determinant | |
| JPH05501401A (ja) | 組換え微生物との転移増殖によるワクチン又はトキソイド製剤及び免疫の方法 | |
| JP2003533990A (ja) | 百日咳菌、パラ百日咳菌および気管支敗血症菌のペルタクチンの繰返し領域の多型性を有するポリペプチド、ならびに診断および免疫原性組成物におけるその使用 | |
| JPH08510714A (ja) | エプスタイン−バーウィルスからの免疫反応性ペプチド | |
| CN111138553B (zh) | 一种融合蛋白及一种弓形虫亚单位疫苗及其疫苗组合物 | |
| CN117024522A (zh) | 针对pik3ca基因e545k突变的肿瘤新抗原多肽及其应用 | |
| JP2003503059A (ja) | 破傷風毒素ポリペプチド | |
| DE60025522T2 (de) | Mycoplasma mycoides subsp. mycoides sc antigenisches lppq protein, seine herstellung und verwendung | |
| CN115850377A (zh) | 基于nras基因q61k突变的肿瘤新抗原多肽及其应用 | |
| AU756866B2 (en) | A mutant human hepatitis B viral strain and uses thereof |